Addressing the challenge of platinum-resistant ovarian cancer: the role of mirvetuximab soravtansine

被引：0
|
作者：
Shaukat, Ayesha [1 ]
Shakeel, Laiba [1 ]
Khan, Afsheen [1 ]
Irfan, Hamza [2 ]
Akilimali, Aymar [3 ]
机构：
[1] Dow Univ Hlth Sci, Dept Internal Med, Karachi, Pakistan
[2] Shaikh Khalifa Bin Zayed Al Nahyan Med & Dent Coll, Dept Internal Med, Lahore, Pakistan
[3] Med Res Circle, Dept Res, Goma, DEM REP CONGO
来源：
ANNALS OF MEDICINE AND SURGERY | 2025年 / 87卷 / 01期
关键词：
EXPRESSION; CISPLATIN; WOMEN;
D O I：
10.1097/MS9.0000000000002759
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 7
页数：7
相关论文
共 50 条
  • [1] Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
    Gonzalez-Ochoa, Eduardo
    Veneziani, Ana C.
    Oza, Amit M.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [2] Mirvetuximab Soravtansine for platinum-resistant Ovarian Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (08) : 882 - 882
  • [3] Mirvetuximab soravtansine for platinum-resistant epithelial ovarian cancer
    Porter, Rebecca L.
    Matulonis, Ursula A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (08) : 783 - 796
  • [4] Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
    Moore, K. N.
    Angelergues, A.
    Konecny, G. E.
    Garcia, Y.
    Banerjee, S.
    Lorusso, D.
    Lee, J. -Y.
    Moroney, J. W.
    Colombo, N.
    Roszak, A.
    Tromp, J.
    Myers, T.
    Lee, J. -W.
    Beiner, M.
    Cosgrove, C. M.
    Cibula, D.
    Martin, L. P.
    Sabatier, R.
    Buscema, J.
    Estevez-Garcia, P.
    Coffman, L.
    Nicum, S.
    Duska, L. R.
    Pignata, S.
    Galvez, F.
    Wang, Y.
    Method, M.
    Berkenblit, A.
    Roufai, D. Bello
    Van Gorp, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (23): : 2162 - 2174
  • [5] A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer
    Moore, Kathleen N.
    Martin, Lainie P.
    O'Malley, David M.
    Matulonis, Ursula A.
    Konner, Jason A.
    Vergote, Ignace
    Ponte, Jose F.
    Birrer, Michael J.
    FUTURE ONCOLOGY, 2018, 14 (02) : 123 - 136
  • [6] Mirvetuximab Soravtansine Improves OS in Patients With Platinum-Resistant Ovarian Cancer
    Coleman, Robert L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (07) : 363 - 364
  • [7] Mirvetuximab soravtansine superior to chemotherapy in platinum-resistant epithelial ovarian cancer
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (02) : 83 - 83
  • [8] Mirvetuximab soravtansine superior to chemotherapy in platinum-resistant epithelial ovarian cancer
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2024, 21 : 83 - 83
  • [9] Mirvetuximab soravtansine: A breakthrough in targeted therapy for platinum-resistant ovarian cancer
    Kokori, Emmanuel
    Olatunji, Gbolahan
    Komolafe, Rosemary
    Abraham, Israel Charles
    Ukoaka, Bonaventure
    Samuel, Owolabi
    Ayodeji, Akinmeji
    Ogunbowale, Ibukunoluwa
    Ezenwoba, Chidiogo
    Aderinto, Nicholas
    MEDICINE, 2024, 103 (20) : E38132
  • [10] Evaluating the Duration of Response With Mirvetuximab Soravtansine for Treating Platinum-Resistant Ovarian Cancer
    Mccaw, Zachary R.
    Tian, Lu
    Wei, Lee-Jen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (29) : 4704 - +
12345